These relationships deliver high quality patient outcomes and advance the management of diseases. While these exchanges and collaborations are essential, they also need to be structured via a healthy and transparent working relationship between the industry and HCPs/HCOs.
The Code regulates in detail how these collaborations, in particular in the field of R&D and HCP medical education (e.g. medical congresses, scholarships etc.) should be structured in order to avoid any resemblance of improperness.